Article Information
History
- November 3, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Bingyi Yang1,2,
- Angkana T. Huang1,2,
- Bernardo Garcia-Carreras1,2,
- William E. Hart3,
- Andrea Staid3,
- Matt D.T. Hitchings1,2,
- Elizabeth C. Lee4,
- Chanelle J. Howe5,
- Kyra H. Grantz4,
- Amy Wesolowksi4,
- Joseph Chadi Lemaitre6,
- Susan Rattigan1,2,
- Carlos Moreno1,2,
- Brooke Borgert1,2,
- Celeste Dale1,
- Nicole Quigley1,
- Andrew Cummings7,
- Alizée McLorg8,
- Kaelene LoMonaco1,
- Sarah Schlossberg9,
- Drew Barron-Kraus1,
- Harrison Shrock1,
- UFCOVID Interventions Team*,
- Justin Lessler4,†,
- Carl D. Laird3,† and
- Derek A.T. Cummings1,2,†
- 1Department of Biology, University of Florida, USA
- 2Emerging Pathogens Institute, University of Florida, USA
- 3Sandia National Laboratories, USA
- 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, USA
- 5Department of Epidemiology, Brown University School of Public Health, USA
- 6Department of Civil and Environmental Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
- 7Department of Mathematics, Syracuse University, USA
- 8Department of Public Health, Syracuse University, USA
- 9Tulane University, USA
- ↵†Correspondence to: Derek A.T. Cummings (datc{at}ufl.edu), Carl D. Laird (cdlaird{at}sandia.gov), Justin Lessler (justin{at}jhu.edu)
Posted November 03, 2020.
Effect of specific non-pharmaceutical intervention policies on SARS-CoV-2 transmission in the counties of the United States
